EU establishes ground rules for AI use in HTA
The HTA CG (Member State Coordination Group on Health Technology Assessment) has published General Principles concerning the use of Artificial Intelligence in the preparation of dossiers for Joint Clinical Assessment (JCA) within Health Technology assessment processes.
For the purposes of the General Principles
First ever national HTA relying on an EU JCA results in rejection of product for reimbursement
The national Health Technology Assessment (“HTA”) by the Irish National Centre for Pharmacoeconomics (“NCPE”) of Novartis’ Itvisma was the first HTA in which, according to the NCPE, an EU Joint Clinical Assessment